Hypoxia Alters Cathepsin B / Inhibitor Profiles in Oral Carcinoma Cell Lines
Overview
Authors
Affiliations
Background: The tumor microenvironment is believed to contribute to the malignant properties of tumor cells in heterogeneous tumor tissues. We investigated the impact of hypoxia (1% oxygen) on the expression of cathepsin B and its natural inhibitors cystatin B and C.
Materials And Methods: Patient-matched oral carcinoma cell lines from primary tumor and lymph node metastasis were used to study the effects of hypoxia on proliferation, protein expression, and proteolytic and inhibitor activities.
Results: Hypoxic growth led to elevated cathepsin B expression and activity, and this effect was greater in metastatic than in primary tumor cells. Also, hypoxia led to down-regulation of the inhibitors cystatin C and B, resulting in increased residual activity of cathepsin B.
Conclusion: These data suggest that the invasive and/or metastatic potential of cells may be enhanced under hypoxia by increasing cathepsin-mediated proteolysis. The results provide strong evidence for the involvement of cathepsin B and its cystatin inhibitors in hypoxia-enhanced tumor progression.
Cathepsin B: A sellsword of cancer progression.
Mijanovic O, Brankovic A, Panin A, Savchuk S, Timashev P, Ulasov I Cancer Lett. 2019; 449:207-214.
PMID: 30796968 PMC: 6488514. DOI: 10.1016/j.canlet.2019.02.035.
Genome-independent hypoxic repression of estrogen receptor alpha in breast cancer cells.
Padro M, Louie R, Lananna B, Krieg A, Timmerman L, Chan D BMC Cancer. 2017; 17(1):203.
PMID: 28320353 PMC: 5358051. DOI: 10.1186/s12885-017-3140-9.
Ibrahim S, El-Ghonaimy E, Hassan H, Mahana N, Mahmoud M, El-Mamlouk T J Adv Res. 2016; 7(5):661-70.
PMID: 27482469 PMC: 4957008. DOI: 10.1016/j.jare.2016.06.007.
Inactivation of tristetraprolin in chronic hypoxia provokes the expression of cathepsin B.
Fuhrmann D, Tausendschon M, Wittig I, Steger M, Ding M, Schmid T Mol Cell Biol. 2014; 35(3):619-30.
PMID: 25452305 PMC: 4285428. DOI: 10.1128/MCB.01034-14.
Hypoxia enhances the antiglioma cytotoxicity of B10, a glycosylated derivative of betulinic acid.
Fischer S, Ronellenfitsch M, Thiepold A, Harter P, Reichert S, Kogel D PLoS One. 2014; 9(4):e94921.
PMID: 24743710 PMC: 3990545. DOI: 10.1371/journal.pone.0094921.